Graystone Company Announces
Initial Product, Fucoidan Longevity Booster
Fort
Lauderdale,
FL --
March 4, 2021 -- InvestorsHub NewsWire -- Graystone
Company, Inc.
(OTC:
GYST)
announced today its
initial product to be launched, "Fucoidan Longevity
Booster."
What is the
"Fucoidan Longevity Booster":
It
is a
powerful anti-inflammatory antioxidant blend with rejuvenating
properties. The main ingredient of this proprietary blend is
fucoidan, a complex polysaccharide found in many species of brown
seaweed. We will use a
nano
Fucoidan Extract which
increases absorption rates up to 5 times.
What is
Fucoidan?
Fucoidans
occur
naturally in the cell walls of brown seaweeds and
function
to protect the plant from water-borne pathogens and other
environmental challenges. Fucoidans are long chain
polysaccharides characterized
by a
complex molecular structure and varying degrees of sulfation and
acetylation. Our Nano Fucoidan Extract is produced
from Okinawan mozuku fucoidan which
is derived
through a patented manufacturing process.
What research has
been done on Fucoidan?
According
to information published by Memorial Sloan Kettering Cancer Center
as of January 2021, studies on fucoidan suggest that it can prevent
the growth of cancer cells and has antiviral, neuroprotective, and
immune-modulating effects. (Memorial Sloan Kettering Cancer
Center).
Additionally,
more
than 2000 independent, peer-reviewed research papers have been
published on the bioactive properties of fucoidan. This extensive
body of evidence includes comprehensive in
vitro investigations,
animal studies and human clinical trials.
Extensive
research has been undertaken on the immune-modulatory properties of
fucoidan. Published papers have reported
that fucoidan may exert
a range of beneficial effects on the human immune system, including
the reduction of allergic responses and the activation of dendritic
cells, natural killer cells
and T
cells. It has also been shown that fucoidan has the potential to
boost important anti-viral and anti-tumour responses.
Research
into the therapeutic properties of fucoidan has largely focused on
the key health indications identified below.
Boosting
immune responses
Immune
responses
to vaccines or infections can be weakened
or inadequate,
particularly during ill health and in older people. In a clinical
setting, ingestion of fucoidan was shown to help boost the immune
responses to seasonal influenza vaccinations (Negishi, 2013). The
ingestion of fucoidan has also been shown to increase the
anti-pathogenic activity of granulocytes (white
blood cells)
and
macrophages (there
are involved in detection,
phagocytosis and destruction of bacteria and other harmful
organisms)
in
healthy people (Myers, 2011).
Increased immune activity after fucoidan ingestion can even
eliminate the tropical protozoan parasite Leishmania, as seen in a
mouse model (Kar, 2011).
Fucoidans can also promote the maturation of dendritic cells,
activate NK cells
and
promote cytotoxic activity (Zhang, 2015).
Cancer
Fucoidan
is most widely known and used for its potential anti-cancer
properties. A considerable amount of research has been undertaken
in this area, with some researchers proposing that fucoidan not
only increases patient wellbeing, but also assists in the treatment
of disease. The potential for fucoidan as an anti-cancer agent is
explored in several review publications, including those by
Fitton
(2015), Kwak
(2014) and Lowenthal
(2014).
Anti-inflammatory
Fucoidan
shows potential therapeutic anti-inflammatory activity,
particularly as a selectin blocker. Fucoidan has potential to
be very
effective in
addressing systemic inflammation, as well as local inflammation in
the digestive tract when orally ingested and on the skin when
applied topically. (Maruyama, 2015)
The
mechanisms of action may include inhibition of inflammatory enzymes
and increased integrity of cellular junctions. Fucoidan may
have therapeutic potential in the treatment of rheumatoid
arthritis. (Shu, 2015)
Anti-ageing
Research
on fucoidan has shown a marked effect on ageing related
processes. Fucoidan can potentially reverse ageing in endothelial
stem cells (Lee, 2015) and
is known to increase sirtuin levels in cell models (Fitton, 2015). In
addition to inhibiting key enzymes associated with human ageing
processes, research has demonstrated that fucoidan may promote
vascular health and stimulate immune responses. It has also been
shown to exhibit neuroprotective properties in animal
models.
In
addition to the above key areas, there are many other potential
niche applications for fucoidan (Fitton,
2015).
These include:
Expected
Launch Date
The
Company is working to finalize the product formulas
for
its Fucoidan Longevity Booster
.
We
estimate
that it we
will
launch our
Fucoidan
Longevity Booster in
July/August 2021.
This information is
of a general nature only and has not been evaluated by the FDA or
other regulatory body. Our fucoidan products are not intended to
treat, cure or prevent any disease and recipients of
this information must exercise their own judgement in determining
the appropriateness for a particular purpose.
About
The Graystone Company,
Inc.
Graystone
Company develops
products
for planned product line
for Longevity
and Wellness. The
Graystone Company, Inc.
(OTC
PINK:GYST)
is headquartered in Fort
Lauderdale, FL., and
can be reached at www.thegraystonecompany.com
or by phone at (954)
271-2704.
Notice Regarding
Forward-Looking Statements in this
press release which are not purely historical are forward-looking
statements and include any statements regarding beliefs,
plans, expectations
or
intentions regarding the future. Actual results could differ from
those projected in any forward-looking statements due to numerous
factors. These forward-looking statements are made as of the date
of this news release, and we assume no obligation to update the
forward-looking statements, or to update the reasons why actual
results could differ from those projected in the forward-looking
statements. Although we believe that any beliefs, plans,
expectations
and
intentions contained in this press release are reasonable, there
can be no assurance that any such beliefs, plans, expectations or
intentions will prove to be accurate.
For more
information:
Graystone
Company
Email:
info@thegraystonecompany.com
Phone:
(954)
271-2704